Literature DB >> 11373275

Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists.

J M Way1, C Z Görgün, Q Tong, K T Uysal, K K Brown, W W Harrington, W R Oliver, T M Willson, S A Kliewer, G S Hotamisligil.   

Abstract

Elevated levels of the hormone resistin, which is secreted by fat cells, are proposed to cause insulin resistance and to serve as a link between obesity and type 2 diabetes. In this report we show that resistin expression is significantly decreased in the white adipose tissue of several different models of obesity including the ob/ob, db/db, tub/tub, and KKA(y) mice compared with their lean counterparts. Furthermore, in response to several different classes of antidiabetic peroxisome proliferator-activated receptor gamma agonists, adipose tissue resistin expression is increased in both ob/ob mice and Zucker diabetic fatty rats. These data demonstrate that experimental obesity in rodents is associated with severely defective resistin expression, and decreases in resistin expression are not required for the antidiabetic actions of peroxisome proliferator-activated receptor gamma agonists.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11373275     DOI: 10.1074/jbc.C100189200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  Resistin overexpression is induced by a beta3 adrenergic agonist in diet-related overweightness.

Authors:  J A Martínez; J Margareto; A Marti; F I Milagro; E Larrarte; M J Moreno Aliaga
Journal:  J Physiol Biochem       Date:  2001-09       Impact factor: 4.158

Review 2.  Regulation of adipocytokines and insulin resistance.

Authors:  M Fasshauer; R Paschke
Journal:  Diabetologia       Date:  2003-11-06       Impact factor: 10.122

Review 3.  Cardiovascular risk associated with the metabolic syndrome.

Authors:  Robert S Lindsay; Barbara V Howard
Journal:  Curr Diab Rep       Date:  2004-02       Impact factor: 4.810

4.  The irresistible biology of resistin.

Authors:  Gökhan S Hotamisligil
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 5.  [Adipokine update - new molecules, new functions].

Authors:  Carmen Gelsinger; Alexander Tschoner; Susanne Kaser; Christoph F Ebenbichler
Journal:  Wien Med Wochenschr       Date:  2010-08

6.  Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue.

Authors:  Christine Kurlawalla-Martinez; Bangyan Stiles; Ying Wang; Sherin U Devaskar; Barbara B Kahn; Hong Wu
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

7.  Human resistin gene polymorphism is associated with visceral obesity and fasting and oral glucose stimulated C-peptide in the Québec Family Study.

Authors:  L Bouchard; S J Weisnagel; J C Engert; T J Hudson; C Bouchard; M C Vohl; L Pérusse
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

8.  Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats.

Authors:  Hiroaki Satoh; M T Audrey Nguyen; Philip D G Miles; Takeshi Imamura; Isao Usui; Jerrold M Olefsky
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 9.  Adipokines and the peripheral and neural control of energy balance.

Authors:  Rexford S Ahima; Mitchell A Lazar
Journal:  Mol Endocrinol       Date:  2008-01-17

10.  Selective disruption of PPARgamma 2 impairs the development of adipose tissue and insulin sensitivity.

Authors:  Jifeng Zhang; Mingui Fu; Taixing Cui; Chen Xiong; Kefeng Xu; Wei Zhong; Yan Xiao; Donna Floyd; Jian Liang; En Li; Qing Song; Yuqing E Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.